Safety and Efficacy of Di-Peptidyl Peptidase-4 Inhibitors in The Management of Inpatient Elderly with Type 2 Diabetes
Ghazi, H., Hegazy, A., Nowara, A. (2023). Safety and Efficacy of Di-Peptidyl Peptidase-4 Inhibitors in The Management of Inpatient Elderly with Type 2 Diabetes. EKB Journal Management System, 90(1), 364-371. doi: 10.21608/ejhm.2023.279618
Hossam Ghazi; Ali Hegazy; Amira Nowara. "Safety and Efficacy of Di-Peptidyl Peptidase-4 Inhibitors in The Management of Inpatient Elderly with Type 2 Diabetes". EKB Journal Management System, 90, 1, 2023, 364-371. doi: 10.21608/ejhm.2023.279618
Ghazi, H., Hegazy, A., Nowara, A. (2023). 'Safety and Efficacy of Di-Peptidyl Peptidase-4 Inhibitors in The Management of Inpatient Elderly with Type 2 Diabetes', EKB Journal Management System, 90(1), pp. 364-371. doi: 10.21608/ejhm.2023.279618
Ghazi, H., Hegazy, A., Nowara, A. Safety and Efficacy of Di-Peptidyl Peptidase-4 Inhibitors in The Management of Inpatient Elderly with Type 2 Diabetes. EKB Journal Management System, 2023; 90(1): 364-371. doi: 10.21608/ejhm.2023.279618